2021
DOI: 10.1016/j.msard.2020.102643
|View full text |Cite
|
Sign up to set email alerts
|

Myelorradiculitis due to Varicella Zoster (Elsberg syndrome) as the first symptom of HIV in a patient with Crohn's disease in use of Infliximab

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 9 publications
0
3
0
Order By: Relevance
“…Antiviral drugs are recommended for the resolution of herpes zoster lesions and to decrease the severity of acute pain 3 . Although the correct acyclovir regimen for ES caused by VZV has not been established, 3 the usual dose that is administered is 5–10 mg/kg q8h for ES without meningitis and 10 mg/kg q8h for ES with meningitis or ES in immunocompromised hosts 9,10 . In the present case, because the only neurological symptom was voiding dysfunction, we administered 5 mg/kg q8h, considering the risk of adverse effects, such as renal toxicity or acyclovir‐induced neurotoxicity, with increasing doses.…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…Antiviral drugs are recommended for the resolution of herpes zoster lesions and to decrease the severity of acute pain 3 . Although the correct acyclovir regimen for ES caused by VZV has not been established, 3 the usual dose that is administered is 5–10 mg/kg q8h for ES without meningitis and 10 mg/kg q8h for ES with meningitis or ES in immunocompromised hosts 9,10 . In the present case, because the only neurological symptom was voiding dysfunction, we administered 5 mg/kg q8h, considering the risk of adverse effects, such as renal toxicity or acyclovir‐induced neurotoxicity, with increasing doses.…”
Section: Discussionmentioning
confidence: 97%
“…3 Although the correct acyclovir regimen for ES caused by VZV has not been established, 3 the usual dose that is administered is 5-10 mg/kg q8h for ES without meningitis and 10 mg/kg q8h for ES with meningitis or ES in immunocompromised hosts. 9,10 In the present case, because the only neurological symptom was voiding dysfunction, we administered 5 mg/kg q8h, considering the risk of adverse effects, such as renal toxicity or acyclovirinduced neurotoxicity, with increasing doses. According to the patient's neurological condition (consistent with meningitis, disseminated lesions, and weakness or paralysis of the lower extremities) and background (age and immunocompromised status due to HIV infection), an individualized dose of acyclovir was considered reasonable.…”
Section: Discussionmentioning
confidence: 99%
“…Although the patient had a partial recovery at discharge, the long-term prognosis was not reported. These cases suggest that short-term treatment with corticosteroid and acyclovir may be ineffective in improving the short-term prognosis [ 13 ].…”
Section: Discussionmentioning
confidence: 99%